Status:
ACTIVE_NOT_RECRUITING
A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands
Lead Sponsor:
Erasmus Medical Center
Conditions:
HIV Infections
HIV-1-infection
Eligibility:
All Genders
18+ years
Brief Summary
A prospective non-interventional cohort study at Erasmus MC of adult chronic HIV infected patients of ≥18 years of age who initiate antiretroviral therapy in routine care.
Detailed Description
HIV cannot be cured with the current treatment armamentarium. A reservoir of latently HIV infected long lived CD4+T-cells is present in patients with HIV that are not affected by antiretroviral therap...
Eligibility Criteria
Inclusion
- Age \>18 years.
- Confirmed HIV-1 or HIV-2 infection
- Judged willing to initiate and adhere to cART by the HIV physician.
Exclusion
- Inability to place venous catheters to draw blood.
- Major comorbidities:
- Severe symptomatic anemia or recent symptomatic cardiovascular event (un-stable angina pectoris, decompensated heart failure, myocardial infarction).
- The inability to participate due to any other relevant social, environmental,psychological, factors or according to the HIV treating physician's judgement.
Key Trial Info
Start Date :
May 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2034
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04888754
Start Date
May 26 2021
End Date
January 1 2034
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, Netherlands, 3015 CN